The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane

All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial pr...

Full description

Saved in:
Bibliographic Details
Published inmBio Vol. 8; no. 4
Main Authors Fontana, Juan, Atanasiu, Doina, Saw, Wan Ting, Gallagher, John R., Cox, Reagan G., Whitbeck, J. Charles, Brown, Lauren M., Eisenberg, Roselyn J., Cohen, Gary H.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 22.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial prefusion conformation to a final postfusion conformation. Strikingly, the prefusion conformation of the herpesvirus fusion protein, gB, is poorly understood. Herpes simplex virus (HSV), a model system for herpesviruses, causes diseases ranging from mild skin lesions to serious encephalitis and neonatal infections. Using cryo-electron tomography and subtomogram averaging, we have characterized the structure of the prefusion conformation and fusion intermediates of HSV-1 gB. To this end, we have set up a system that generates microvesicles displaying full-length gB on their envelope. We confirmed proper folding of gB by nondenaturing electrophoresis-Western blotting with a panel of monoclonal antibodies (MAbs) covering all gB domains. To elucidate the arrangement of gB domains, we labeled them by using (i) mutagenesis to insert fluorescent proteins at specific positions, (ii) coexpression of gB with Fabs for a neutralizing MAb with known binding sites, and (iii) incubation of gB with an antibody directed against the fusion loops. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB’s conformational rearrangements during fusion. These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and therefore infectivity. IMPORTANCE The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB’s domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection. The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB’s domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection.
AbstractList All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial prefusion conformation to a final postfusion conformation. Strikingly, the prefusion conformation of the herpesvirus fusion protein, gB, is poorly understood. Herpes simplex virus (HSV), a model system for herpesviruses, causes diseases ranging from mild skin lesions to serious encephalitis and neonatal infections. Using cryo-electron tomography and subtomogram averaging, we have characterized the structure of the prefusion conformation and fusion intermediates of HSV-1 gB. To this end, we have set up a system that generates microvesicles displaying full-length gB on their envelope. We confirmed proper folding of gB by nondenaturing electrophoresis-Western blotting with a panel of monoclonal antibodies (MAbs) covering all gB domains. To elucidate the arrangement of gB domains, we labeled them by using (i) mutagenesis to insert fluorescent proteins at specific positions, (ii) coexpression of gB with Fabs for a neutralizing MAb with known binding sites, and (iii) incubation of gB with an antibody directed against the fusion loops. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB’s conformational rearrangements during fusion. These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and therefore infectivity. The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB’s domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection.
All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial prefusion conformation to a final postfusion conformation. Strikingly, the prefusion conformation of the herpesvirus fusion protein, gB, is poorly understood. Herpes simplex virus (HSV), a model system for herpesviruses, causes diseases ranging from mild skin lesions to serious encephalitis and neonatal infections. Using cryo-electron tomography and subtomogram averaging, we have characterized the structure of the prefusion conformation and fusion intermediates of HSV-1 gB. To this end, we have set up a system that generates microvesicles displaying full-length gB on their envelope. We confirmed proper folding of gB by nondenaturing electrophoresis-Western blotting with a panel of monoclonal antibodies (MAbs) covering all gB domains. To elucidate the arrangement of gB domains, we labeled them by using (i) mutagenesis to insert fluorescent proteins at specific positions, (ii) coexpression of gB with Fabs for a neutralizing MAb with known binding sites, and (iii) incubation of gB with an antibody directed against the fusion loops. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB's conformational rearrangements during fusion. These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and therefore infectivity.IMPORTANCE The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB's domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection.All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial prefusion conformation to a final postfusion conformation. Strikingly, the prefusion conformation of the herpesvirus fusion protein, gB, is poorly understood. Herpes simplex virus (HSV), a model system for herpesviruses, causes diseases ranging from mild skin lesions to serious encephalitis and neonatal infections. Using cryo-electron tomography and subtomogram averaging, we have characterized the structure of the prefusion conformation and fusion intermediates of HSV-1 gB. To this end, we have set up a system that generates microvesicles displaying full-length gB on their envelope. We confirmed proper folding of gB by nondenaturing electrophoresis-Western blotting with a panel of monoclonal antibodies (MAbs) covering all gB domains. To elucidate the arrangement of gB domains, we labeled them by using (i) mutagenesis to insert fluorescent proteins at specific positions, (ii) coexpression of gB with Fabs for a neutralizing MAb with known binding sites, and (iii) incubation of gB with an antibody directed against the fusion loops. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB's conformational rearrangements during fusion. These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and therefore infectivity.IMPORTANCE The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB's domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection.
ABSTRACT All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial prefusion conformation to a final postfusion conformation. Strikingly, the prefusion conformation of the herpesvirus fusion protein, gB, is poorly understood. Herpes simplex virus (HSV), a model system for herpesviruses, causes diseases ranging from mild skin lesions to serious encephalitis and neonatal infections. Using cryo-electron tomography and subtomogram averaging, we have characterized the structure of the prefusion conformation and fusion intermediates of HSV-1 gB. To this end, we have set up a system that generates microvesicles displaying full-length gB on their envelope. We confirmed proper folding of gB by nondenaturing electrophoresis-Western blotting with a panel of monoclonal antibodies (MAbs) covering all gB domains. To elucidate the arrangement of gB domains, we labeled them by using (i) mutagenesis to insert fluorescent proteins at specific positions, (ii) coexpression of gB with Fabs for a neutralizing MAb with known binding sites, and (iii) incubation of gB with an antibody directed against the fusion loops. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB’s conformational rearrangements during fusion. These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and therefore infectivity. IMPORTANCE The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB’s domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection.
All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial prefusion conformation to a final postfusion conformation. Strikingly, the prefusion conformation of the herpesvirus fusion protein, gB, is poorly understood. Herpes simplex virus (HSV), a model system for herpesviruses, causes diseases ranging from mild skin lesions to serious encephalitis and neonatal infections. Using cryo-electron tomography and subtomogram averaging, we have characterized the structure of the prefusion conformation and fusion intermediates of HSV-1 gB. To this end, we have set up a system that generates microvesicles displaying full-length gB on their envelope. We confirmed proper folding of gB by nondenaturing electrophoresis-Western blotting with a panel of monoclonal antibodies (MAbs) covering all gB domains. To elucidate the arrangement of gB domains, we labeled them by using (i) mutagenesis to insert fluorescent proteins at specific positions, (ii) coexpression of gB with Fabs for a neutralizing MAb with known binding sites, and (iii) incubation of gB with an antibody directed against the fusion loops. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB’s conformational rearrangements during fusion. These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and therefore infectivity. IMPORTANCE The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB’s domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection. The herpesvirus family includes herpes simplex virus (HSV) and other human viruses that cause lifelong infections and a variety of diseases, like skin lesions, encephalitis, and cancers. As enveloped viruses, herpesviruses must fuse their envelope with the host membrane to start an infection. This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). However, the prefusion conformation of the herpesvirus fusion protein (gB) is poorly understood. To elucidate the structure of the prefusion conformation of HSV type 1 gB, we have employed cryo-electron microscopy to study gB molecules expressed on the surface of vesicles. Using different approaches to label gB’s domains allowed us to model the structures of the prefusion and intermediate conformations of gB. Overall, our findings enhance our understanding of HSV fusion and lay the groundwork for the development of new ways to prevent and block HSV infection.
Author Atanasiu, Doina
Whitbeck, J. Charles
Brown, Lauren M.
Cox, Reagan G.
Cohen, Gary H.
Fontana, Juan
Gallagher, John R.
Saw, Wan Ting
Eisenberg, Roselyn J.
Author_xml – sequence: 1
  givenname: Juan
  orcidid: 0000-0002-9084-2927
  surname: Fontana
  fullname: Fontana, Juan
  organization: Faculty of Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom
– sequence: 2
  givenname: Doina
  surname: Atanasiu
  fullname: Atanasiu, Doina
  organization: Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 3
  givenname: Wan Ting
  surname: Saw
  fullname: Saw, Wan Ting
  organization: Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 4
  givenname: John R.
  surname: Gallagher
  fullname: Gallagher, John R.
  organization: Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 5
  givenname: Reagan G.
  surname: Cox
  fullname: Cox, Reagan G.
  organization: Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 6
  givenname: J. Charles
  surname: Whitbeck
  fullname: Whitbeck, J. Charles
  organization: Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 7
  givenname: Lauren M.
  surname: Brown
  fullname: Brown, Lauren M.
  organization: Faculty of Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom
– sequence: 8
  givenname: Roselyn J.
  surname: Eisenberg
  fullname: Eisenberg, Roselyn J.
  organization: Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
– sequence: 9
  givenname: Gary H.
  surname: Cohen
  fullname: Cohen, Gary H.
  organization: Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28830949$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1v1DAQhi1URD_okSvKkUtKxlnH9gUJVrRdaRGVWLhaE9tpXSVxsJ1C_z3e3baiSPgy9szrZ8aeOSYHox8tIW-gOgOg4v3wyfmzCmgjSuAvyBEFVpWcARxs9w2UFKg8JKcx3lZ51TWIunpFDqnIVi7kEbnf3NjifI7Oj8Xa-ykWvitS9q1Glxz2xVWw3T689GPnw4Bpe8iqSxsmG4tvbph6-7v44cIcC3iEXQWfrMvWuzEVG_8Lg9mBv9ihDTja1-Rlh320pw_2hHw__7xZXpbrrxer5cd1qRnIVFIjOW1y4ai11ZyC5rioKTJhRSc1FfnNiwZNhYh11xlKTdsKiY3uFqaWuj4hqz3XeLxVU3ADhnvl0amdw4drhSE53VvVWtNVhjUW6pyDS2TIgXImGGVaNJhZH_asaW4Ha7QdU8D-GfR5ZHQ36trfKcYaJjlkwLsHQPA_ZxuTGlzUtu_zh_g5KpA1ZBnnMkvf_p3rKclj77Kg3At08DHmNj1JoFLb8VDb8VC78VDAs77-R69d2nUzl-r6_9z6A6PXv90
CitedBy_id crossref_primary_10_1093_infdis_jiy194
crossref_primary_10_1128_JVI_01050_21
crossref_primary_10_1016_j_omtm_2019_12_013
crossref_primary_10_1128_mSphere_00826_19
crossref_primary_10_1371_journal_ppat_1007452
crossref_primary_10_1016_j_jdermsci_2018_09_006
crossref_primary_10_1371_journal_ppat_1008961
crossref_primary_10_1186_s43556_024_00199_7
crossref_primary_10_3390_pathogens10010061
crossref_primary_10_1128_jvi_01533_24
crossref_primary_10_1146_annurev_virology_021920_115935
crossref_primary_10_1038_s41579_020_00448_w
crossref_primary_10_1172_JCI161968
crossref_primary_10_3390_v13081637
crossref_primary_10_1128_jvi_01194_24
crossref_primary_10_1038_s41594_018_0060_6
crossref_primary_10_1016_j_jmb_2018_04_015
crossref_primary_10_1126_sciadv_abc1726
crossref_primary_10_1128_JVI_01694_18
crossref_primary_10_1128_mBio_01948_18
crossref_primary_10_1128_mbio_01864_22
crossref_primary_10_2217_fvl_2017_0124
crossref_primary_10_1016_j_tibs_2024_06_012
crossref_primary_10_3390_v16010012
crossref_primary_10_1128_JVI_00983_20
crossref_primary_10_1038_s41467_023_43011_w
crossref_primary_10_3390_v13061178
crossref_primary_10_1038_s41467_020_17911_0
crossref_primary_10_1038_s41541_018_0074_4
Cites_doi 10.1128/JVI.01714-16
10.1016/j.jsb.2005.07.007
10.1016/j.str.2009.10.009
10.1016/j.virol.2015.03.043
10.1128/JVI.02687-09
10.1126/science.1090284
10.1016/S1097-2765(01)00298-2
10.1126/science.1126548
10.1038/ncomms9176
10.1371/journal.ppat.1002556
10.1073/pnas.1618883114
10.1038/nsmb.1837
10.1128/JVI.03200-13
10.1038/nrmicro2548
10.1128/JVI.01700-13
10.1371/journal.ppat.1004373
10.1038/mt.2011.138
10.1073/pnas.0810530106
10.1128/jvi.63.5.2325-2334.1989
10.1073/pnas.1011806108
10.1016/j.str.2014.09.005
10.1128/jvi.60.1.157-166.1986
10.1128/JVI.00301-09
10.1006/jsbi.2001.4406
10.1080/10409230802058320
10.1128/JVI.79.18.11588-11597.2005
10.1073/pnas.1501176112
10.1128/JVI.02391-15
10.1073/pnas.1011507107
10.3390/v4050800
10.1006/viro.2000.0713
10.1371/journal.ppat.1004377
10.1111/tra.12389
10.1038/ncomms1571
10.1016/j.jmb.2013.03.001
10.1128/JVI.01750-10
10.1371/journal.ppat.1005564
10.1083/jcb.201006116
10.1371/journal.ppat.1002277
10.1371/journal.ppat.1005227
10.1126/science.1234914
10.1038/sj.emboj.7600875
10.1128/JVI.72.7.6119-6130.1998
10.1038/ncomms13557
10.1128/JVI.01501-16
10.1126/science.272.5259.263
10.1128/JVI.01906-14
10.1126/science.1127683
10.1073/pnas.1523234113
10.1128/JVI.01700-10
10.1126/science.1135710
10.1016/j.coviro.2017.04.006
10.1128/JVI.02204-15
10.1016/j.jsb.2007.08.002
10.1128/mBio.00429-12
10.1128/JVI.02710-06
10.1002/jcc.20084
ContentType Journal Article
Contributor Longnecker, Richard
Carfi, Andrea
Contributor_xml – sequence: 1
  givenname: Andrea
  surname: Carfi
  fullname: Carfi, Andrea
– sequence: 2
  givenname: Richard
  surname: Longnecker
  fullname: Longnecker, Richard
Copyright Copyright © 2017 Fontana et al.
Copyright © 2017 Fontana et al. 2017 Fontana et al.
Copyright_xml – notice: Copyright © 2017 Fontana et al.
– notice: Copyright © 2017 Fontana et al. 2017 Fontana et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1128/mBio.01268-17
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Prefusion and Intermediate Conformations of HSV-1 gB
EISSN 2150-7511
ExternalDocumentID oai_doaj_org_article_bedf0d56e13a4379a5a712758525c86a
PMC5565971
28830949
10_1128_mBio_01268_17
Genre Journal Article
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: T32 NS007180
– fundername: NIGMS NIH HHS
  grantid: P41 GM103311
– fundername: Wellcome Trust
  grantid: 090932/Z/09/Z
– fundername: Wellcome Trust
– fundername: NIAID NIH HHS
  grantid: R01 AI018289
– fundername: HHS | National Institutes of Health (NIH)
  grantid: 5T32NS007180
– fundername: Intramural Research Program of NIAMS, NIH
– fundername: University of Leeds
– fundername: HHS | National Institutes of Health (NIH)
  grantid: R01-AI-18289
GroupedDBID ---
0R~
53G
5VS
AAFWJ
AAGFI
AAUOK
AAYXX
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
CITATION
DIK
E3Z
EBS
EJD
FRP
GROUPED_DOAJ
GX1
H13
HYE
HZ~
KQ8
M48
O5R
O5S
O9-
OK1
P2P
PGMZT
RHI
RNS
RPM
RSF
CGR
CUY
CVF
ECM
EIF
M~E
NPM
RHF
7X8
5PM
ID FETCH-LOGICAL-c519t-2d9726318accec721c7a432a58e8f9c2821546ad0aaa3ffd22dbb89a6cf4d39c3
IEDL.DBID M48
ISSN 2161-2129
2150-7511
IngestDate Wed Aug 27 01:32:28 EDT 2025
Thu Aug 21 18:31:00 EDT 2025
Fri Jul 11 00:35:31 EDT 2025
Wed Feb 19 02:31:36 EST 2025
Thu Apr 24 22:53:12 EDT 2025
Tue Jul 01 01:52:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords prefusion
viral fusion
herpesviruses
neutralizing antibodies
subtomogram averaging
HSV
cryo-electron tomography
gB
microvesicles
cryo-electron microscopy
Language English
License Copyright © 2017 Fontana et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c519t-2d9726318accec721c7a432a58e8f9c2821546ad0aaa3ffd22dbb89a6cf4d39c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article is a direct contribution from a Fellow of the American Academy of Microbiology. Solicited external reviewers: Andrea Carfi, Valera LLC, Moderna Therapeutics; Richard Longnecker, Northwestern University Feinberg School of Medicine.
J.F. and D.A. contributed equally to this work.
Present address: John R. Gallagher, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA; J. Charles Whitbeck, Integral Molecular, Philadelphia, Pennsylvania, USA.
ORCID 0000-0002-9084-2927
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1128/mBio.01268-17
PMID 28830949
PQID 1931713779
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_bedf0d56e13a4379a5a712758525c86a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5565971
proquest_miscellaneous_1931713779
pubmed_primary_28830949
crossref_primary_10_1128_mBio_01268_17
crossref_citationtrail_10_1128_mBio_01268_17
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20170822
PublicationDateYYYYMMDD 2017-08-22
PublicationDate_xml – month: 8
  year: 2017
  text: 20170822
  day: 22
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle mBio
PublicationTitleAlternate mBio
PublicationYear 2017
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_3_50_2
e_1_3_3_16_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_58_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_56_2
e_1_3_3_33_2
e_1_3_3_54_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_52_2
e_1_3_3_40_2
World Health Organization (e_1_3_3_2_2) 2017
e_1_3_3_5_2
e_1_3_3_7_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_23_2
e_1_3_3_48_2
e_1_3_3_25_2
e_1_3_3_46_2
e_1_3_3_44_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
e_1_3_3_51_2
e_1_3_3_17_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_59_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_57_2
e_1_3_3_32_2
e_1_3_3_55_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_53_2
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_28_2
e_1_3_3_49_2
e_1_3_3_24_2
e_1_3_3_47_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
References_xml – ident: e_1_3_3_23_2
  doi: 10.1128/JVI.01714-16
– ident: e_1_3_3_55_2
  doi: 10.1016/j.jsb.2005.07.007
– ident: e_1_3_3_58_2
  doi: 10.1016/j.str.2009.10.009
– ident: e_1_3_3_42_2
  doi: 10.1016/j.virol.2015.03.043
– ident: e_1_3_3_25_2
  doi: 10.1128/JVI.02687-09
– ident: e_1_3_3_30_2
  doi: 10.1126/science.1090284
– ident: e_1_3_3_7_2
  doi: 10.1016/S1097-2765(01)00298-2
– ident: e_1_3_3_12_2
  doi: 10.1126/science.1126548
– ident: e_1_3_3_18_2
  doi: 10.1038/ncomms9176
– ident: e_1_3_3_48_2
  doi: 10.1371/journal.ppat.1002556
– ident: e_1_3_3_49_2
  doi: 10.1073/pnas.1618883114
– ident: e_1_3_3_11_2
  doi: 10.1038/nsmb.1837
– ident: e_1_3_3_24_2
  doi: 10.1128/JVI.03200-13
– ident: e_1_3_3_22_2
  doi: 10.1038/nrmicro2548
– ident: e_1_3_3_34_2
  doi: 10.1128/JVI.01700-13
– ident: e_1_3_3_35_2
  doi: 10.1371/journal.ppat.1004373
– ident: e_1_3_3_38_2
  doi: 10.1038/mt.2011.138
– ident: e_1_3_3_16_2
  doi: 10.1073/pnas.0810530106
– ident: e_1_3_3_53_2
  doi: 10.1128/jvi.63.5.2325-2334.1989
– ident: e_1_3_3_14_2
  doi: 10.1073/pnas.1011806108
– ident: e_1_3_3_39_2
  doi: 10.1016/j.str.2014.09.005
– volume-title: Herpes simplex virus
  year: 2017
  ident: e_1_3_3_2_2
– ident: e_1_3_3_40_2
  doi: 10.1128/jvi.60.1.157-166.1986
– ident: e_1_3_3_27_2
  doi: 10.1128/JVI.00301-09
– ident: e_1_3_3_57_2
  doi: 10.1006/jsbi.2001.4406
– ident: e_1_3_3_3_2
  doi: 10.1080/10409230802058320
– ident: e_1_3_3_26_2
  doi: 10.1128/JVI.79.18.11588-11597.2005
– ident: e_1_3_3_20_2
  doi: 10.1073/pnas.1501176112
– ident: e_1_3_3_45_2
  doi: 10.1128/JVI.02391-15
– ident: e_1_3_3_19_2
  doi: 10.1073/pnas.1011507107
– ident: e_1_3_3_5_2
  doi: 10.3390/v4050800
– ident: e_1_3_3_52_2
  doi: 10.1006/viro.2000.0713
– ident: e_1_3_3_36_2
  doi: 10.1371/journal.ppat.1004377
– ident: e_1_3_3_46_2
  doi: 10.1111/tra.12389
– ident: e_1_3_3_10_2
  doi: 10.1038/ncomms1571
– ident: e_1_3_3_29_2
  doi: 10.1016/j.jmb.2013.03.001
– ident: e_1_3_3_13_2
  doi: 10.1128/JVI.01750-10
– ident: e_1_3_3_44_2
  doi: 10.1371/journal.ppat.1005564
– ident: e_1_3_3_50_2
  doi: 10.1083/jcb.201006116
– ident: e_1_3_3_8_2
  doi: 10.1371/journal.ppat.1002277
– ident: e_1_3_3_17_2
  doi: 10.1371/journal.ppat.1005227
– ident: e_1_3_3_41_2
  doi: 10.1126/science.1234914
– ident: e_1_3_3_6_2
  doi: 10.1038/sj.emboj.7600875
– ident: e_1_3_3_47_2
  doi: 10.1128/JVI.72.7.6119-6130.1998
– ident: e_1_3_3_15_2
  doi: 10.1038/ncomms13557
– ident: e_1_3_3_21_2
  doi: 10.1128/JVI.01501-16
– ident: e_1_3_3_37_2
  doi: 10.1126/science.272.5259.263
– ident: e_1_3_3_9_2
  doi: 10.1128/JVI.01906-14
– ident: e_1_3_3_32_2
  doi: 10.1126/science.1127683
– ident: e_1_3_3_31_2
  doi: 10.1073/pnas.1523234113
– ident: e_1_3_3_43_2
  doi: 10.1128/JVI.01700-10
– ident: e_1_3_3_33_2
  doi: 10.1126/science.1135710
– ident: e_1_3_3_4_2
  doi: 10.1016/j.coviro.2017.04.006
– ident: e_1_3_3_54_2
  doi: 10.1128/JVI.02204-15
– ident: e_1_3_3_56_2
  doi: 10.1016/j.jsb.2007.08.002
– ident: e_1_3_3_51_2
  doi: 10.1128/mBio.00429-12
– ident: e_1_3_3_28_2
  doi: 10.1128/JVI.02710-06
– ident: e_1_3_3_59_2
  doi: 10.1002/jcc.20084
SSID ssj0000331830
Score 2.3263369
Snippet All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this...
ABSTRACT All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Animals
Antibodies, Monoclonal - immunology
Chlorocebus aethiops
cryo-electron microscopy
cryo-electron tomography
Cryoelectron Microscopy
Herpes Simplex - immunology
Herpes Simplex - prevention & control
Herpes Simplex - virology
Herpesvirus 1, Human - chemistry
Herpesvirus 1, Human - physiology
herpesviruses
HSV
Membrane Fusion
Models, Molecular
Mutagenesis
Protein Conformation
subtomogram averaging
Vero Cells
Viral Envelope Proteins - chemistry
Viral Envelope Proteins - metabolism
Viral Fusion Proteins - chemistry
Viral Fusion Proteins - metabolism
Virus Internalization
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhEMil9JG22xcKhJzqxpZtyTomocumNCHQpOQmRg9TQ2Iv-4D232dGXi-7paWXngzWWBYzI-kbe_QNY0e4LZQ2tTqxBUBSBBkSDd4mtkZ4koGwOtBp5MsrObktvtyVdxulvignrKcH7hV3YoOvU1_KkOVA3HlQgiJS8qoUpatkhEa4520EU3ENzslX04FUU1QnD2dN9wlXY4lBk9rahCJX_58A5u95khsbz_gpe7JCjPy0H-kzthPa52yvryH56wWjynN8vKSPXvxr103nvKs5ojp-QWlB-OA1vr5vptN9w1lFkpqE2TTM-beGGIJ_8u_NbDnn2dDZNTE4NHjtmnbBb2J6bez4MjxgiN2GA3Y7_nxzPklW9RQShzhtkQivlZCoGHAuOAz9nEKVCiirUNXaYfCFeEqCTwEgr2svhLe20iBdXfhcu_wl2227NrxmPCuEq6yG4HJdBCs1KHAWp78PIH2ejdjHQcHGrcjGqebFvYlBh6gM2cNEe5hMjdjxWnzas2z8TfCMrLUWInLseANdxqxcxvzLZUbscLC1wclEf0hQad1ybhDNZipyMI7Yq97261dRWWaMhbFFbXnF1li2W9rmRyTsLhE1a5W9-R-Df8v2BSGLFBc48Y7tLmbL8B5x0cJ-iFPgEbyrDqQ
  priority: 102
  providerName: Directory of Open Access Journals
Title The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane
URI https://www.ncbi.nlm.nih.gov/pubmed/28830949
https://www.proquest.com/docview/1931713779
https://pubmed.ncbi.nlm.nih.gov/PMC5565971
https://doaj.org/article/bedf0d56e13a4379a5a712758525c86a
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagCIkL4t3lURkJcSIlcRInPiBEEcuCWFSJLtpbNH4EIrXJkuxK7b9nxkkWtio3LokUP-Xx2N84nm8Ye4HbQqpDrQKdAASJky5QYHWgS4QnEQitHHkjz7_K2SL5vEyXfyiFhgHsrjTtKJ7Uoj09PP918RYV_k3vAJO_PjuqmkNcaCXaQ9l1dgM3pYyCGcwHpO8X5ZgmbziybF4utbMrefL-qxDn5YuTf-1E0zvs9gAh-bte5nfZNVffYzf7oJIX9xmFouPTDZ2C8S9Ns-p4U3KEefwT3RPCgsfYfJ9M7n6j8yLlmrl25Tr-rSLK4HP-vWo3HY_Gyo6J0qHCd1PVa37i79v6iufuDG3u2j1gi-mHk_ezYAiwEBgEbutAWJUJiQMDxjiDtqDJIIkFpLnLS2XQGkOAJcGGABCXpRXCap0rkKZMbKxM_JDt1U3t9hmPEmFyrcCZWCVOSwUZGI3rgXUgbRxN2KtxgAszsI9TEIzTwlshIi9IHoWXRxFlE_Zym33V0278K-MRSWubidiy_Yem_VEMyldoZ8vQptJFMRD_IqSQEbF9norU5BIm7Pko6wK1i36Z4KA1m65AeBtlnpRxwh71st82RXGa0TjGlGxnVuz0ZTelrn56Bu8UYbTKosf_o_NP2C1BUCPEFU88ZXvrduOeIVBa6wN_wIDPj8vowKvDbzdAF9Q
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Fusion+Loops+of+the+Initial+Prefusion+Conformation+of+Herpes+Simplex+Virus+1+Fusion+Protein+Point+Toward+the+Membrane&rft.jtitle=mBio&rft.au=Juan+Fontana&rft.au=Doina+Atanasiu&rft.au=Wan+Ting+Saw&rft.au=John+R.+Gallagher&rft.date=2017-08-22&rft.pub=American+Society+for+Microbiology&rft.eissn=2150-7511&rft.volume=8&rft.issue=4&rft_id=info:doi/10.1128%2FmBio.01268-17&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bedf0d56e13a4379a5a712758525c86a
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon